Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

NCT00437450 is registered in ClinicalTrials.gov with Groupe Francophone des Myelodysplasies as lead sponsor.

NCT NCT00437450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00437450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
Lead sponsor
Groupe Francophone des Myelodysplasies
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2004
Completion date
September 30, 2005
Enrollment
99
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

anemia in myelodysplastic syndromes